AtriCure launches AtriClip Pro-V in the US

AtriCure (NSDQ:ATRC) said today it launched its AtriClip Pro-V left atrial appendate exclusion system in the US. The newly launched AtriClip Pro-V is designed to be placed through a minimally-invasive surgery and features an open-ended design and tip-first closure mechanism for easier navigation, the Mason, Ohio.-based company claims. “Development of the AtriClip Pro-V is another step in the direction of a comprehensive strategy for management of the left atrial appendage. It expands the options for minimally invasive approaches including right chest access and an easier implantation of an epicardial atrial appendage clip. AtriCure has been consistently working for decades to improve patients’ lives by offering devices for atrial fibrillation ablation and left atrial appendage closure. Development of this new AtriClip device is another significant step in this direction, which improves access to the appendage and makes it easier to visualize and apply the AtriClip at the base of the appendage utilizing minimally invasive techniques. Our team at Pinnacle Health is privileged to be part of this development,” Dr. Mubashir A. Mumtaz of Pennsylvania’s Pinnacle Health said in a press release. AtriCure said that the Pro-V has identical force and pressure specifications to other closed-end designed AtriClip devices, including the Flex and Pro2, and that the device is compatible with 12mm ports and can be repositioned multiple times before deployment. “The A...
Source: Mass Device - Category: Medical Devices Authors: Tags: Business/Financial News Cardiac Implants Cardiovascular Replacement Heart Valves AtriCure Inc. Source Type: news